C. Diff clinical trials at UCSF
1 research study open to eligible people
Showing trials for
Fecal Microbiota Transplant National Registry
open to all eligible people
A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness
San Francisco, California and other locations
Our lead scientists for C. Diff research studies include Max Brondfield, MD.
Last updated: